Article Information
PubMed
History
- Published online February 21, 2012.
Article Versions
- Latest version (January 16, 2012 - 08:41).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 Canadian Medical Association or its licensors
Author Information
- Michael R. Law, PhD⇑,
- Lucy Cheng, MSc,
- Irfan A. Dhalla, MD MSc,
- Deborah Heard, BASc,
- Steven G. Morgan, PhD
- Centre for Health Services and Policy Research (Law, Cheng, Heard, Morgan), School of Population and Public Health, University of British Columbia, Vancouver, BC; the Department of Medicine (Dhalla), University of Toronto, Toronto, Ont.; the Li Ka Shing Knowledge Institute (Dhalla), St. Michael’s Hospital, Toronto, Ont.; and the Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
- Correspondence to:
Dr. Michael R. Law, mlaw{at}chspr.ubc.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
- Effect of free distribution of medicines on the process of care for adult patients with type 1 and type 2 diabetes and hypertension: post hoc analysis of randomised controlled trial findings
- Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes
- The mirage of universality: Canadas failure to act on social policy and health care
- Exploring the experiences of people in Ontario, Canada who have trouble affording medicines: a qualitative concept mapping study
- Compliance packaging: Be aware of the hidden cost
- Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
- Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study
- Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study
- Should national pharmacare apply a value-based insurance design?
- Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study
- Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study
- Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis
- Improving the quality of health care in Canada
- The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
- Testing and treatment for obstructive sleep apnea in Canada: funding models must change
- Social considerations of inflammatory bowel disease in Southern Israel
- Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial
- Impact of income-based deductibles on drug use and health care utilization among older adults
- Lacces aux medicaments par lhospitalisation
- Medication access via hospital admission
- Liste canadienne des medicaments essentiels: Potentiel et incertitudes
- Canadian list of essential medications: Potential and uncertainties
- Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs
- The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study
- Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada
- Development of a preliminary essential medicines list for Canada
- Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries
- Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey
- Estimated cost of universal public coverage of prescription drugs in Canada
- Delivering on the promise of Medicare
- Concretiser les promesses du regime d'assurance-maladie
- Addressing cost-related barriers to prescription drug use in Canada
- Chronic Physical and Mental Health Conditions among Adults May Increase Vulnerability to Household Food Insecurity
- The road to competitive generic drug prices in Canada
- Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes
- Leadership on prescription drugs needed
More in this TOC Section
Similar Articles
Collections
